Concepedia

Brinda Emu

BE

28

Publications

4.4K

Citations

20

H-Index

1997

Active since

Affiliations

Yale University(Current)

University of California, San Francisco

San Francisco General Hospital

National Institutes of Health

VA Connecticut Healthcare System

Brinda Emu is an author at Yale University specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

1997–2023

28

Publications

28

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister, Nicolás Gonzalo Núñez, Roser Pinyol et al. · Nature · 2021 · 1.2K citations · Full text

Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors

Shihao Xu, Omkar Chaudhary, Patricia Rodríguez-Morales et al. · Immunity · 2021 · 673 citations · Full text

, , +9

Relationship between T Cell Activation and CD4 <sup>+</sup> T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

Peter W. Hunt, Jason M. Brenchley, Elizabeth Sinclair et al. · The Journal of Infectious Diseases · 2007 · 635 citations

Phase 3 Study of Ibalizumab for Multidrug-Resistant HIV-1

Brinda Emu, Jeffrey Fessel, Shannon Schrader et al. · New England Journal of Medicine · 2018 · 220 citations · Full text

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study

Thomas S. Uldrick, Priscila Gonçalves, Maher Abdul‐Hay et al. · JAMA Oncology · 2019 · 220 citations · Full text

Rows per page

1–5 of 28